TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive In Brief: House Hearing On NCI Budget Is March 16; NIH Reauthorization Sent To Senate Floor February 14, 1992
TCL Archive Cooperative Groups Should Be Trimmed, Brought Under Control Of DCT, Surgical Panel Suggests May 31, 1974